Fort Point Capital Partners LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 58 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Fort Point Capital Partners LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$125,000
-12.0%
156,100
+1.3%
0.06%
-17.9%
Q4 2016$142,000
+27.9%
154,100
+2.7%
0.08%
+56.0%
Q3 2016$111,000
-29.3%
150,100
+23.6%
0.05%
-34.2%
Q2 2016$157,000
-42.9%
121,400
-0.8%
0.08%
-45.7%
Q1 2016$275,000
-15.1%
122,400
+32.1%
0.14%
-15.2%
Q4 2015$324,00092,6540.16%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Shilanski & Associates, Inc. 937,237$57,0000.02%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$57,0000.02%
CVA Family Office, LLC 1,137,920$69,0000.02%
Cypress Capital Management LLC (WY) 140,925$9,0000.01%
Helen Stephens Group, LLC 117,222$7,0000.01%
COURIER CAPITAL LLC 540,056$33,0000.00%
NORTHCAPE WEALTH MANAGEMENT, LLC 98,000$6,0000.00%
Newbridge Financial Services Group, Inc. 10,000$1,0000.00%
Western Wealth Management, LLC 352,950$11,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 606,800$37,0000.00%
View complete list of AMPIO PHARMACEUTICALS INC shareholders